These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32764879)

  • 1. A Synthetic Peptide 2Abz
    Moazzezy N; Asadi Karam MR; Rafati S; Bouzari S; Oloomi M
    Drug Des Devel Ther; 2020; 14():2797-2807. PubMed ID: 32764879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crude polysaccharides from the seeds of Vaccaria segetalis prevent the urinary tract infection through the stimulation of kidney innate immunity.
    Mao X; Guo H; Yao R; Bao L; Sun J; Bao Y; Guo B; Gao Y; Shi Y; Zhang H; Cui X
    J Ethnopharmacol; 2020 Oct; 260():112578. PubMed ID: 31962152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uropathogenic
    Li ZP; Li J; Li TL; Song ZY; Gong XZ
    Front Cell Infect Microbiol; 2024; 14():1322119. PubMed ID: 38638825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
    Lin AE; Beasley FC; Olson J; Keller N; Shalwitz RA; Hannan TJ; Hultgren SJ; Nizet V
    PLoS Pathog; 2015 Apr; 11(4):e1004818. PubMed ID: 25927232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RpoS contributes to phagocyte oxidase-mediated stress resistance during urinary tract infection by Escherichia coli CFT073.
    Hryckowian AJ; Welch RA
    mBio; 2013 Feb; 4(1):e00023-13. PubMed ID: 23404396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
    Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
    mBio; 2012; 3(1):. PubMed ID: 22318320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
    Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
    Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous extract from Orthosiphon stamineus leaves prevents bladder and kidney infection in mice.
    Sarshar S; Brandt S; Asadi Karam MR; Habibi M; Bouzari S; Lechtenberg M; Dobrindt U; Qin X; Goycoolea FM; Hensel A
    Phytomedicine; 2017 May; 28():1-9. PubMed ID: 28478807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNase 7 Inhibits Uropathogenic
    Ho CH; Liao PW; Fan CK; Liu SP; Cheng PC
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of multiple cytokines to stratify uropathogenic Escherichia coli pathogenesis in mouse model of urinary tract infection.
    Koley S; Mukherjee M
    Cytokine; 2024 Jun; 178():156577. PubMed ID: 38479049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiadhesive hydroalcoholic extract from Apium graveolens fruits prevents bladder and kidney infection against uropathogenic E. coli.
    Sarshar S; Sendker J; Qin X; Goycoolea FM; Asadi Karam MR; Habibi M; Bouzari S; Dobrindt U; Hensel A
    Fitoterapia; 2018 Jun; 127():237-244. PubMed ID: 29496563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073.
    Palaniyandi S; Mitra A; Herren CD; Lockatell CV; Johnson DE; Zhu X; Mukhopadhyay S
    PLoS One; 2012; 7(2):e31348. PubMed ID: 22363626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune response to bacterial urinary tract infection sensitises high-threshold bladder afferents and recruits silent nociceptors.
    Brierley SM; Goh KGK; Sullivan MJ; Moore KH; Ulett GC; Grundy L
    Pain; 2020 Jan; 161(1):202-210. PubMed ID: 31479069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-step strategies for synergistic treatment of urinary tract infections based on D-xylose-decorated antimicrobial peptide carbon dots.
    Miao C; Zhang Y; Liu G; Yang J; Yu K; Lv J; Liu R; Yao Z; Niu Y; Wang X; Wang Q
    Biomaterials; 2024 Jul; 308():122547. PubMed ID: 38537344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction of chronic Escherichia coli urinary tract infection depends upon T cell-derived interleukin-17, a deficiency of which predisposes to flagella-driven bacterial persistence.
    Chamoun MN; Sullivan MJ; Goh KGK; Acharya D; Ipe DS; Katupitiya L; Gosling D; Peters KM; Sweet MJ; Sester DP; Schembri MA; Ulett GC
    FASEB J; 2020 Nov; 34(11):14572-14587. PubMed ID: 32901999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
    Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of uropathogenic Escherichia coli outer membrane protein T in pathogenesis of urinary tract infection.
    He XL; Wang Q; Peng L; Qu YR; Puthiyakunnon S; Liu XL; Hui CY; Boddu S; Cao H; Huang SH
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25825479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low concentrations of human neutrophil peptide ameliorate experimental murine colitis.
    Maeda T; Sakiyama T; Kanmura S; Hashimoto S; Ibusuki K; Tanoue S; Komaki Y; Arima S; Nasu Y; Sasaki F; Taguchi H; Numata M; Uto H; Tsubouchi H; Ido A
    Int J Mol Med; 2016 Dec; 38(6):1777-1785. PubMed ID: 27840892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.